These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2488504)

  • 41. Siblings with pediatric sodium chlorite toxicity causing methemoglobinemia, renal failure and hemolytic anemia.
    Zhen J; Hakmeh W
    Am J Emerg Med; 2021 Apr; 42():262.e3-262.e4. PubMed ID: 32948394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin E and dapsone-induced hemolysis.
    Kelly JW; Scott J; Sandland M; Van der Weyden MB; Marks R
    Arch Dermatol; 1984 Dec; 120(12):1582-4. PubMed ID: 6508329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dapsone-associated Heinz body hemolytic anemia in a Cambodian woman with hemoglobin E trait.
    Lachant NA; Tanaka KR
    Am J Med Sci; 1987 Nov; 294(5):364-8. PubMed ID: 3425586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.
    Cheah CY; Lew TE; Seymour JF; Burbury K
    Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Full dapsone dose made possible by control of anaemia with darbepoetin-alpha.
    Flosadóttir E; Bjarnason B
    Acta Derm Venereol; 2008; 88(5):540-1. PubMed ID: 18779910
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pyramidon-induced agranulocytosis: transient marrow aplasia of the three myeloid differentiation lines. Marrow recovery followed by secondary hypoplasia].
    Flandrin G; Daniel MT; Brière J; Varet B; Pestel M; Bernard J
    Nouv Rev Fr Hematol; 1971; 11(2):219-31. PubMed ID: 4252675
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hemolysis, methemoglobinemia and renal failure in a 30-year-old patient].
    Hillebrand G; Mittermüller J
    Internist (Berl); 1988 May; 29(5):364-7. PubMed ID: 3042679
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute methemoglobinemia and hemolytic anemia with phenazopyridine: possible relation to acute renal failure.
    Nathan DM; Siegel AJ; Bunn HF
    Arch Intern Med; 1977 Nov; 137(11):1636-8. PubMed ID: 921457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DRUG INDUCED BLOOD DISORDERS.
    GIRDWOOD RH
    Br J Clin Pract; 1964 Nov; 18():701-7. PubMed ID: 14230852
    [No Abstract]   [Full Text] [Related]  

  • 50. [Disulone and hepatosiderosis].
    Darrieux L; Adamski H; Turlin B; Ollivier I; Polard E; Deugnier Y; Chevrant-Breton J
    Ann Dermatol Venereol; 2006; 133(8-9 Pt 1):683-5. PubMed ID: 17053738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
    Doury P; Fabresse FX; Pattin S; Eulry F; Celton H; Larroque P
    Ann Med Interne (Paris); 1984; 135(1):31-5. PubMed ID: 6703568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone.
    Lewis JA; Petty WJ; Harmon M; Peacock JE; Valente K; Owen J; Pirmohamed M; Lesser GJ
    J Oncol Pharm Pract; 2015 Jun; 21(3):220-3. PubMed ID: 24576944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dapsone-associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis.
    Woodbury GR; Fried W; Ertle JO; Malkinson FD
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):781-3. PubMed ID: 8496428
    [No Abstract]   [Full Text] [Related]  

  • 55. Hemolytic anemia induced by dapsone transmitted through breast milk.
    Sanders SW; Zone JJ; Foltz RL; Tolman KG; Rollins DE
    Ann Intern Med; 1982 Apr; 96(4):465-6. PubMed ID: 7065565
    [No Abstract]   [Full Text] [Related]  

  • 56. Hemolytic anemia in patients receiving sulfasalazine.
    Goodacre RL; Ali MA; Vanderlinden B; Hamilton JD; Castelli M; Seaton T
    Digestion; 1978; 17(6):503-8. PubMed ID: 30666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia.
    Ashurst JV; Wasson MN; Hauger W; Fritz WT
    J Am Osteopath Assoc; 2010 Jan; 110(1):16-20. PubMed ID: 20093649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Reports on blood disorders in alcoholism].
    Heck J
    Minerva Med; 1973 May; 64(31):1691-2. PubMed ID: 4715413
    [No Abstract]   [Full Text] [Related]  

  • 59. Worsening oxygen saturation during treatment with oxidative drugs: a clinical reminder.
    Driver JA; Lynn J; Dhanjal US
    JAMA; 1996 Oct; 276(15):1221-2. PubMed ID: 8849747
    [No Abstract]   [Full Text] [Related]  

  • 60. Dapsone-induced methemoglobinemia: case report and literature review.
    Zosel A; Rychter K; Leikin JB
    Am J Ther; 2007; 14(6):585-7. PubMed ID: 18090884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.